Chapter 3 │ Page 111 71. Španko, M., et al., IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives. Int J Mol Sci, 2021. 22(20). 72. Zhao, M., et al., Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res, 2011. 17(23): p. 7248-64. 73. Gioanni, J., et al., Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol, 1988. 24(9): p. 1445-55. 74. Mannino, M.H., et al., The paradoxical role of IL-10 in immunity and cancer. Cancer Letters, 2015. 367(2): p. 103-107. 75. Rébé, C. and F. Ghiringhelli, Interleukin-1β and Cancer. Cancers (Basel), 2020. 12(7). 76. Abdul-Rahman, T., et al., The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review. European Journal of Medical Research, 2024. 29(1): p. 124. 77. Bornstein, S., et al., IL-10 and integrin signaling pathways are associated with head and neck cancer progression. BMC Genomics, 2016. 17: p. 38. 78. Xu, Q., et al., The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway. Cell Death & Disease, 2020. 11(5): p. 405. 79. Nisar, S., et al. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. International Journal of Molecular Sciences, 2021. 22, DOI: 10.3390/ijms22094584. 80. Pittet, M.J., et al., Dendritic cells as shepherds of T cell immunity in cancer. Immunity, 2023. 56(10): p. 2218-2230. 81. Vahle, A.K., et al., Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice--role of toll-like-receptor 4 expressed on host cells. Cancer Lett, 2012. 317(2): p. 199-206. 82. Brand, M., et al., Characterization and Di erentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice. Int J Mol Sci, 2020. 22(1). 83. Metelmann, H.-R., et al., Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer. Clinical Plasma Medicine, 2018. 9: p. 6-13. 84. Schuster, M., et al., Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer. Journal of Cranio-Maxillofacial Surgery, 2016. 44(9): p. 1445-1452.
RkJQdWJsaXNoZXIy MTk4NDMw